Content tagged "immunotherapy":

Oldridge Lab

The Oldridge lab studies the intricate spatial biology of intact tissues, combining cutting-edge spatialomic techniques with advanced computational, statistical, and AI-driven analytic methods. These approaches are used to deeply profile tissues with hundreds to thousands of molecular markers in a spatially detailed manner, in order to better understand the molecular, cellular, and structural basis of human health and disease.

Read more

Deng Lab

Development and application of new technologies for spatial omics profiling at the cellular level, specifically tools at the intersection of microchip, microscopy, genomics, and computational analysis to profile genome, epigenome, transcriptome, and proteome within the spatial context of tissues and cells.
Principal Investigator: Yanxiang Deng, PhD

Read more

Nicholas K. Brown, PhD, F(ACHI)

Associate Professor of Clinical Pathology and Laboratory Medicine
Perelman School of Medicine at the University of Pennsylvania

Associate Director, Histocompatibility Testing Laboratory

Beatriz M. Carreno, PhD
Research Professor of Pathology and Laboratory Medicine
Perelman School of Medicine at the University of Pennsylvania

Lambris Lab

The Lambris Lab consists of an international and interdisciplinary team that investigates the various aspects of innate immunity, and particularly the complement system, in health and disease. The integrated research approach encompasses projects such as the quantitative analysis of protein-protein interactions of complement components, the development of therapeutic complement inhibitors (e.g. Compstatin), complement evasion by human pathogens, and the role of complement in liver regeneration and cancer development.

Read more

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

October 16, 2014

Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) who had relapsed multiple times or failed to respond to standard therapies went into remission after receiving an investigational personalized cellular therapy, CTL019, developed at the Perelman School of Medicine at the University of Pennsylvania. The unprecedented results are published this week in The New England Journal of Medicine.

Read more

Center for Advanced Cellular Therapeutics (CACT)

September 11, 2014

Construction of a first-of-its-kind Center for Advanced Cellular Therapeutics at Penn Medicine has begun.

Read more

Vijay Bhoj, MD, PhD
Assistant Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Perelman School of Medicine at the University of Pennsylvania

Findings from Research Study of Leukemia Patients Announced at ASH Annual Meeting

December 06, 2013

 The latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies.

Read more

Gene Therapy Pioneers

November 19, 2013

The peer-reviewed journal Human Gene Therapy is celebrating its 25th anniversary in 2014 by publishing a series of Perspectives by top researchers in the field of cell and gene therapy. Five "Pioneer" scientists from the Perelman School of Medicine at the University of Pennsylvania are among the 21 investigators who will be honored throughout the next 12 months.

Read more

Pages